Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
Newsfeed
Shop
Resources
twitter
facebook
linkedin
youtube
instagram
tiktok
Patients
Understanding NF
Neurofibromatosis Type 1
NF2
-Related Schwannomatosis
Schwannomatosis
Find a Doctor
NF Treatments
NF Registry
Resources
Patient Engagement
Clinical Trials
Healthcare Professionals
Diagnostic Criteria
Conferences & Education
Training Grants
Clinical Trials Pipeline
Researchers
Funding Opportunities
Conferences & Education
Research Tools & Resources
Pharma
For Pharma & Biotech
Industry Partnerships
Progress
Our Mission
Our Impact
About Us
Progress in Neurofibromatosis Type 1
Progress in
NF2
-Related Schwannomatosis
Progress in Schwannomatosis
Take Action
Make a Donation
Shine a Light on NF
NF Registry
Share Your Story
search
Donate
News
The latest news, stories, and updates from the Children's Tumor Foundation.
Search for:
Filter
Featured EU
Global
Top Story EU
Collaborations & Partnerships
Global
Press Release
Children’s Tumor Foundation’s Montse Montaner Joins CureAge Therapeutics
Seasoned international advisor will serve on the board of CureAge Therapeutics The Children's Tumor Foundation…
Advocacy
Awareness
Featured
Featured EU
Pharma
From NF to the World: Rare Disease Day and the Race for Faster Treatments
This has been a February to remember! In just a few weeks, a new drug…
Collaborations & Partnerships
Featured
Featured EU
NF1
Pharma
Press Release
Science & Research
Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of NF1
Healx has dosed the first patient in its Phase 2 trial for HLX-1502 - the…
Featured EU
CTF Europe Brochure in Multiple Languages
We are pleased to share our new trifold brochure about CTF Europe, now available in…
Collaborations & Partnerships
Featured
Featured EU
NF1
Pharma
Press Release
Science & Research
CureAge Therapeutics Launches to Advance Genetic Therapies for Neurofibromatosis
Children’s Tumor Foundation and Deep Science Ventures Spearhead New Biotech to Develop Curative Treatments for…
NF1
Pharma
Science & Research
Top Story
Top Story EU
IT’S A GO! NF’s NEXT BIG WIN!
Today, we make history... again! The FDA has officially approved Gomekli (mirdametinib) - the second-ever…
Awards & Grants
Featured
Featured EU
NF1
Science & Research
Young Investigator: Q&A with Alex Dyson about NF1 and brain mechanisms
The Young Investigator Award (YIA) provides two-year salary support to early-career NF researchers to help…
Awareness
Featured
Featured EU
Good2Give Podcast: Understanding and Combating NF: Insights from the Children’s Tumor Foundation
Click here to jump to the podcast transcript. An episode of the Good2Give Podcast, hosted…
Awards & Grants
Featured
Featured EU
NF2-SWN
Making NF Visible in Germany
The Children’s Tumor Foundation is proud to provide funding to Lars Björn Riecken, PhD, and…
Collaborations & Partnerships
Featured EU
NF1
Press Release
Science & Research
Top Story
Children’s Tumor Foundation and CureNFwithJack Announce Next Phase of the Groundbreaking Biomarker Project for NF1 Tumor Detection
Collaboration Accelerates the Development of a Non-Invasive Blood Test to Identify and Track Cancerous Tumors…
Awards & Grants
Featured
Featured EU
CTF Clinical Research Awards
At the Children's Tumor Foundation (CTF), our commitment to advancing neurofibromatosis and schwannomatosis (NF) research…
Awards & Grants
Featured
Featured EU
2024 Drug Discovery Initiative Awardees
The Children’s Tumor Foundation is pleased to announce a significant investment of more than $995,000…
Close Menu
Donate
Patients
Understanding NF
Neurofibromatosis Type 1
NF2
-Related Schwannomatosis
Schwannomatosis
Find a Doctor
NF Treatments
NF Registry
Resources
Patient Engagement
Clinical Trials
Healthcare Professionals
Diagnostic Criteria
Conferences & Education
Training Grants
Clinical Trials Pipeline
Researchers
Funding Opportunities
Conferences & Education
Research Tools & Resources
Pharma
For Pharma & Biotech
Industry Partnerships
Progress
Our Mission
Our Impact
About Us
Progress in Neurofibromatosis Type 1
Progress in
NF2
-Related Schwannomatosis
Progress in Schwannomatosis
Take Action
Make a Donation
Shine a Light on NF
NF Registry
Share Your Story
Newsfeed
Shop
Resources